Impact of Diabetes | Life Changing Innovation
The medical technology industry is continually advancing and developing new innovations that improve the health and well-being of patients worldwide.
What is Diabetes?
Diabetes is a group of diseases characterized by high blood glucose, or blood sugar, caused when the body either does not produce enough insulin or is unable to use insulin in an effective way. When not controlled, the high level of glucose can lead to serious health complications, including death.1
Did You Know
Managing Diabetes with Medical Technology Solutions
- The HbA1c blood test helps diagnose pre-diabetes, Type 1 and 2 diabetes and then to gauge how well a person is managing the disease so that physicians can appropriately tailor treatments.
- Most recently, the FDA approved a hybrid closed loop insulin delivery system that combines advanced, continuous glucose monitoring with a smart algorithm that for the first time, personalizes the delivery of insulin.
Centers for Disease Control and Prevention. Diabetes Report Card 2012. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2012.
Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
Ibid
American Diabetes Association. Economic Cost of Diabetes in the US in 2012. [published online ahead of print March 6, 2013] Diabetes Care. DOI:10.2337/dc12-2625.
Facchinetti A, et al. Real-Time Improvement of Continuous Glucose Monitoring Accuracy. Diabetes Care 2013; 36(4): 793-800.
Hirsch LJ, et al. Impact of a Modified Needle Tip Geometry on Penetration Force as well as Acceptability, Preference, and Perceived Pain in Subjects with Diabetes. J Diabetes Sci Technol 2012;6(2):328-35.
Aronson R, et al. Insulin pen needles: Effects of extra thin-wall needle technology on preference, confidence, and other patient ratings. Clin Ther 2013;35(7):923-933.
Aronson R. The role of comfort and discomfort in insulin therapy. Diabetes Technol The 2012;14(8):1-7.
NICE. (2008). Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. Review of technology appraisal guidance 57. NICE technology appraisal guidance 151.